Mkts

Agios Pharmaceuticals, Inc.

NASDAQ: AGIO
$37.19+0.01 (+0.03%)
As of Oct 22, 4:00 PM ET

Key statistics

Day range
36.3537.74
52-week range
22.2446.00
Today
Open37.22
Previous close37.19
Volume—
Valuation
Market cap2.22B
P/E ratio—
EPS (TTM)-7.01
Income & risk
Dividend / yield—
Beta0.62
Avg volume1.14M
Discussion

AGIO News

Stories mentioning AGIO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue20,74619,96712,88012,4558,72610,7308,9648,615
Cost of Goods Sold1,3191,8791,6791,7021,0851,260783.001,495
Gross Profit19,42718,08811,20110,7537,6419,4708,1817,120
Operating Expenses
Research & Development81,14888,05686,79691,94072,74382,81072,45577,401
Sales General & Admin48,30451,61041,27445,86941,52751,69738,53735,536
Total Operating Expenses
Operating Income (Loss)(110,025)(121,578)(116,869)(127,056)(106,629)(125,037)(102,811)(105,817)
Interest Income
Interest Expense
Other Expense119.00113.0067.00523.001,2531,6231,6511,579
Pretax Income(103,433)1,001,035
Tax Provision0.0053,120
Net Income (Loss)(99,111)(108,039)(103,433)(112,020)(89,289)(96,523)947,915(96,118)
Earnings Per Share (Basic)(1.69)(1.86)(1.78)(1.93)(1.55)(1.70)16.65(1.69)
Earnings Per Share (Diluted)(1.69)(1.86)(1.78)(1.93)(1.55)(1.67)16.22(1.69)
Weighted Average Shares Outstanding (Basic)58,78257,97258,13957,93357,45956,80756,93956,803
Weighted Average Shares Outstanding (Diluted)58,78257,97258,13957,93357,45957,88958,43356,803

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AGIO

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol AGIO. It last traded at $37.19 (Oct 22, 2026, 4:00 PM ET), up 0.0% on the day. That gives Agios Pharmaceuticals a market capitalisation of $2.2B.

Over the past 52 weeks AGIO has traded between $22.24 and $46.00.

Revenue for the quarter ended Mar 31, 2026 was $20.7M; a net loss of $99.1M. Revenue was up 138% from $8.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$20.7M-$99.1M-477.7%
Dec 31, 2025$20.0M-$108.0M-541.1%
Sep 30, 2025$12.9M-$103.4M-803.1%
Jun 30, 2025$12.5M-$112.0M-899.4%

From Agios Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…